Abiopharma

🔍 Control Empresarial de Capitales S.A. de C.V. (Executive)

Company: PBF Energy Inc. (PBF)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Sold 110,000 shares of Class A Common Shares (as defined in Exhibit 99.1 hereto) at $68.2184 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 14,822,128.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 110,375 shares of Class A Common Shares (as defined in Exhibit 99.1 hereto) at $69.1383 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 14,771,753.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Sold 150,000 shares of Class A Common Shares (as defined in Exhibit 99.1 hereto) at $70.1338 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 14,621,753.00 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: Weighted average price. These shares were sold in multiple transactions at prices ranging from $68.00 to $68.40 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
• F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $69.00 to $69.50 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
• F3: Weighted average price. These shares were sold in multiple transactions at prices ranging from $69.80 to $70.72 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
• F4: See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference.